Skip to main content
Sister Publication Links
  • ESG: THE IMPLEMENTATION IMPERATIVE
Subscribe
  • Sign Up Free
  • Login
  • Subscribe
  • News
    • Current News
    • Providers
    • Insurance
    • Digital Health
    • Government
    • Finance
    • Technology
    • Safety & Quality
    • Transformation
    • People
    • Regional News
    • Digital Edition (Web Version)
    • Patients
    • Operations
    • Care Delivery
    • Payment
    • Midwest
    • Northeast
    • South
    • West
  • Unwell in America
  • Opinion
    • Bold Moves
    • Breaking Bias
    • Commentaries
    • Letters
    • Vital Signs Blog
    • From the Editor
  • Events & Awards
    • Awards
    • Conferences
    • Galas
    • Virtual Briefings
    • Webinars
    • Nominate/Eligibility
    • 100 Most Influential People
    • 50 Most Influential Clinical Executives
    • Best Places to Work in Healthcare
    • Excellence in Governance
    • Health Care Hall of Fame
    • Healthcare Marketing Impact Awards
    • Top 25 Emerging Leaders
    • Top 25 Innovators
    • Diversity in Healthcare
      • - Luminaries
      • - Top 25 Diversity Leaders
      • - Leaders to Watch
    • Women in Healthcare
      • - Luminaries
      • - Top 25 Women Leaders
      • - Women to Watch
    • Digital Health Transformation Summit
    • ESG: The Implementation Imperative Summit
    • Leadership Symposium
    • Social Determinants of Health Symposium
    • Women Leaders in Healthcare Conference
    • Best Places to Work Awards Gala
    • Health Care Hall of Fame Gala
    • Top 25 Diversity Leaders Gala
    • Top 25 Women Leaders Gala
    • - Hospital of the Future
    • - Value Based Care
    • - Hospital at Home
    • - Workplace of the Future
    • - Digital Health
    • - Future of Staffing
    • - Hospital of the Future (Fall)
  • Multimedia
    • Podcast - Beyond the Byline
    • Sponsored Podcast - Healthcare Insider
    • Video Series - The Check Up
    • Sponsored Video Series - One on One
  • Data Center
    • Data Center Home
    • Hospital Financials
    • Staffing & Compensation
    • Quality & Safety
    • Mergers & Acquisitions
    • Data Archive
    • Resource Guide: By the Numbers
    • Surveys
    • Data Points
  • MORE+
    • Contact Us
    • Advertise
    • Media Kit
    • Newsletters
    • Jobs
    • People on the Move
    • Reprints & Licensing
MENU
Breadcrumb
  1. Home
  2. Technology
December 15, 2015 12:00 AM

Industry-funded studies rise as federally funded studies dip

Sabriya Rice
  • Tweet
  • Share
  • Share
  • Email
  • More
    Reprints Print

    A new study shows that while clinical research funded by industry groups is growing at a fast clip, research paid for by the government is dropping. Findings published Tuesday in JAMA show that between 2006 and 2014, the number of trials paid for by industry rose 43% while those funded by the National Institutes of Health dropped 24%.

    Researchers say industry-sponsored trials concentrate on commercial purposes, while independent studies better inform the public by comparing those products with existing alternatives, like other drugs and lifestyle or dietary interventions.

    “Those kinds of trials are not typically funded by industry,” said study co-author Dr. Stephan Ehrhardt, associate professor in the Johns Hopkins Bloomberg School of Public Health. “But they really inform the health of the public, and answer more than 'does a drug work, yes or no?' ”

    Trials conducted by for-profit organizations are also more likely to only report positive outcomes. Lastly, the findings speak to other ongoing criticisms about the costs, review process and other limitations of clinical research in the U.S.

    Of 18,400 trials registered in 2014 on clinicaltrials.gov, the federal registry and results database of clinical studies involving human participants, more than a third were sponsored by drug or device manufacturers, according to findings.

    There has been mounting concern by patient safety advocates over the past decade that too often adverse events are under-reported by researchers. That issue was tackled by the National Academy of Medicine in January when the group issued four recommendations to address practices that left relevant medical research unpublished. Independent researchers wishing to make comparisons said they couldn't access important and relevant data.

    But the “failing to report” problem is not just limited to industry. A STAT news investigation published this week found some of the worst offenders included academic institutions that are top recipients of NIH funding.

    The 21st Century Cures Act, recently passed by the House, added a new element of worry. The bill would provide an additional $9.3 billion over the next five years to fund the NIH and support breakthroughs in biomedical research, and allow the agency to speed up the review and market approval of breakthrough drugs. Critics worry, however, that the bill relies too heavily on post-market surveillance for flagging adverse events, a system that has proven to be ineffective.

    In the meantime, the number of newly registered trials on the government's clinical trial database has doubled over the past decade. The research letter posted Tuesday in JAMA found that the number rose from 9,321 in 2006.

    “There is now more competition for limited dollars,” said Ehrhardt. “That leaves less space for these relatively important trials that inform public health.”

    The authors also evaluated whether during the time that the NIH funded fewer studies, the agency had become more selective in terms of the size and scope of the limited studies selected. They looked at the median sample size of NIH funded trials across the years and found no difference.

    The NIH agreed that budget constraints in part explain the decline, but also said it has been proactive in figuring out ways to make trials faster, better and less expensive.

    According to a 2014 report from HHS' Office of the Assistant Secretary for Planning and Evaluation, cost is one of the major obstacles to conducting clinical trials in the U.S. The estimated cost of bringing a new drug to market can range from $161 million to $2 billion.

    “What we are after is an ecosystem in which we can fund more high-impact, cost-effective trials,” said Dr. Michael Lauer, NIH deputy director for extramural research via e-mail.

    It's not just about raw counts of trials, but other deeper measures of investment and impact, he said. “We think about costs, cost per patient enrolled, speed of completion and publication, rate of dissemination, and impact on practice and policy.”

    The agency says it offers funding opportunities for low-cost, pragmatic, patient-centered randomized controlled intervention trials and is also an active partner in the Patient-Centered Outcomes Research Institute.

    PCORI, an independent organization created through a provision of the Affordable Care Act, supports research that assesses which healthcare interventions are most effective. Since it launched in 2012, the institute says it has approved $1.18 billion in funding for 468 patient-centered outcomes research projects.

    The studies it funds look at both patient and stakeholder engagement, and offer comparisons of therapies of all kinds, including drugs, devices, lifestyle interventions, care delivery models, surgical procedures and behavioral health therapies. However, the group has been criticized because the funding program does not support applications to conduct studies of cost-effectiveness.

    Ehrhardt says questions about what to research reveal another concern: What ultimately constitutes a good study in the first place? He agrees with concerns raised by ethics researchers and others in a recent Modern Healthcare report highlighting potential problems in the research review process. “We don't even know what a good ethical review is; we don't have quality criteria,” he said.

    Letter
    to the
    Editor

    Send us a letter

    Have an opinion about this story? Click here to submit a Letter to the Editor, and we may publish it in print.

    Recommended for You
    IBM Quantum System One at Cleveland Clinic_4_0.jpg
    Cleveland Clinic, IBM unveil quantum computer
    Dr. Alice Zheng
    Women's digital health sector poised for growth, venture capitalist predicts
    Most Popular
    1
    More healthcare organizations at risk of credit default, Moody's says
    2
    Centene fills out senior executive team with new president, COO
    3
    SCAN, CareOregon plan to merge into the HealthRight Group
    4
    Blue Cross Blue Shield of Michigan unveils big push that lets physicians take on risk, reap rewards
    5
    Bright Health weighs reverse stock split as delisting looms
    Sponsored Content
    Health IT Strategist (HITS) Newsletter: Sign up for the latest IT and medical technology news delivered 3 days a week (M, W, F).
     
    Get Newsletters

    Sign up for enewsletters and alerts to receive breaking news and in-depth coverage of healthcare events and trends, as they happen, right to your inbox.

    Subscribe Today
    MH Magazine Cover

    MH magazine offers content that sheds light on healthcare leaders’ complex choices and touch points—from strategy, governance, leadership development and finance to operations, clinical care, and marketing.

    Subscribe
    Connect with Us
    • LinkedIn
    • Twitter
    • Facebook
    • RSS

    Our Mission

    Modern Healthcare empowers industry leaders to succeed by providing unbiased reporting of the news, insights, analysis and data.

    Contact Us

    (877) 812-1581

    Email us

     

    Resources
    • Contact Us
    • Advertise with Us
    • Ad Choices Ad Choices
    • Sitemap
    Editorial Dept
    • Submission Guidelines
    • Code of Ethics
    • Awards
    • About Us
    Legal
    • Terms and Conditions
    • Privacy Policy
    • Privacy Request
    Modern Healthcare
    Copyright © 1996-2023. Crain Communications, Inc. All Rights Reserved.
    • News
      • Current News
      • Providers
      • Insurance
      • Digital Health
      • Government
      • Finance
      • Technology
      • Safety & Quality
      • Transformation
        • Patients
        • Operations
        • Care Delivery
        • Payment
      • People
      • Regional News
        • Midwest
        • Northeast
        • South
        • West
      • Digital Edition (Web Version)
    • Unwell in America
    • Opinion
      • Bold Moves
      • Breaking Bias
      • Commentaries
      • Letters
      • Vital Signs Blog
      • From the Editor
    • Events & Awards
      • Awards
        • Nominate/Eligibility
        • 100 Most Influential People
        • 50 Most Influential Clinical Executives
        • Best Places to Work in Healthcare
        • Excellence in Governance
        • Health Care Hall of Fame
        • Healthcare Marketing Impact Awards
        • Top 25 Emerging Leaders
        • Top 25 Innovators
        • Diversity in Healthcare
          • - Luminaries
          • - Top 25 Diversity Leaders
          • - Leaders to Watch
        • Women in Healthcare
          • - Luminaries
          • - Top 25 Women Leaders
          • - Women to Watch
      • Conferences
        • Digital Health Transformation Summit
        • ESG: The Implementation Imperative Summit
        • Leadership Symposium
        • Social Determinants of Health Symposium
        • Women Leaders in Healthcare Conference
      • Galas
        • Best Places to Work Awards Gala
        • Health Care Hall of Fame Gala
        • Top 25 Diversity Leaders Gala
        • Top 25 Women Leaders Gala
      • Virtual Briefings
        • - Hospital of the Future
        • - Value Based Care
        • - Hospital at Home
        • - Workplace of the Future
        • - Digital Health
        • - Future of Staffing
        • - Hospital of the Future (Fall)
      • Webinars
    • Multimedia
      • Podcast - Beyond the Byline
      • Sponsored Podcast - Healthcare Insider
      • Video Series - The Check Up
      • Sponsored Video Series - One on One
    • Data Center
      • Data Center Home
      • Hospital Financials
      • Staffing & Compensation
      • Quality & Safety
      • Mergers & Acquisitions
      • Data Archive
      • Resource Guide: By the Numbers
      • Surveys
      • Data Points
    • MORE+
      • Contact Us
      • Advertise
      • Media Kit
      • Newsletters
      • Jobs
      • People on the Move
      • Reprints & Licensing